Mapping-guided atrial lead placement determines optimal conduction across Bachmann’s bundle: a rationale for patient-tailored pacing therapy
EP Europace · 15.04.2023 · 25 (4) · 1432-1440
DOI: 10.1093/europace/euad039 ↗Kurz gefasst
Fachartikel in der Zeitschrift EP Europace, online erschienen am 16.02.2023. Verfasst von Mathijs S van Schie und 5 weiteren Autor:innen. Beteiligte Einrichtung: Unit Translational Electrophysiology, Department of Cardiology, Erasmus Medical Center, Dr. Molewaterplein 40, 3015GD Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Atrial Fibrillation. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO-Vidi), Biosense Webster, Medical Delta (Netherlands).
Abstract (Originalsprache)
Aims
Conventional right atrial appendage (RAA) pacing is associated with increased atrial activation time resulting in higher incidences of atrial tachyarrhythmia. Optimal pacing sites ideally shorten inter-atrial conduction delay, thereby decreasing atrial excitation time. We therefore examined the impact of programmed electrical stimulation (PES) from the right atrium (RA) and left atrium (LA) on the electrophysiological properties of Bachmann’s bundle (BB). Methods and results High-resolution epicardial mapping of BB was performed during sinus rhythm (SR) and PES in 34 patients undergoing cardiac surgery. Programmed electrical stimulation was performed from the RAA, junction of the RA with inferior caval vein (LRA), and left atrial appendage (LAA). Pacing from either the RAA or LAA resulted in, respectively, right- and left-sided conduction across BB. However, during LRA pacing in most patients (n = 15), activation started in the centre of BB. The total activation time (TAT) of BB during RAA pacing [63 (55–78) ms] was similar to that of SR [61 (52–68) ms, P = 0.464], while it decreased during LRA [45 (39–62) ms, P = 0.003] and increased during LAA pacing [67 (61–75) ms, P = 0.009]. Reduction of both conduction disorders and TAT was most often achieved during LRA pacing (N = 13), especially in patients who already had a higher amount of conduction disorders during SR [9.8 (7.3–12.3) vs. 4.5 (3.5–6.6)%, P < 0.001].
Conclusion
Pacing from the LRA results in a remarkable decrease of TAT compared with pacing from the LAA or RAA. As the most optimal pacing site varies between patients, individualized positioning of the atrial pacing lead guided by mapping of BB may be one of the new frontiers for atrial pacing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Unit Translational Electrophysiology, Department of Cardiology, Erasmus Medical Center, Dr. Molewaterplein 40, 3015GD Rotterdam, The Netherlands.
- Department of Cardiothoracic Surgery, Erasmus Medical Center, Rotterdam, The Netherlands.
ORCID-Profile: Mathijs S van Schie, Nawin L Ramdat Misier, Natasja M S de Groot
Förderung
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO-Vidi)
- Biosense Webster
- Medical Delta (Netherlands)
Zitieren
APA
van Schie, M. S., Ramdat Misier, N. L., Knops, P., Heida, A., Taverne, Y. J. H. J., & de Groot, N. M. S. (2023). Mapping-guided atrial lead placement determines optimal conduction across Bachmann’s bundle: a rationale for patient-tailored pacing therapy. EP Europace, 25(4), 1432-1440. https://doi.org/10.1093/europace/euad039
Vancouver
van Schie MS, Ramdat Misier NL, Knops P, Heida A, Taverne YJHJ, de Groot NMS. Mapping-guided atrial lead placement determines optimal conduction across Bachmann’s bundle: a rationale for patient-tailored pacing therapy. EP Europace. 2023;25(4):1432-1440. doi:10.1093/europace/euad039
BibTeX
@article{vanSchie2023,
author = {van Schie, Mathijs S and Ramdat Misier, Nawin L and Knops, Paul and Heida, Annejet and Taverne, Yannick J H J and de Groot, Natasja M S},
title = {Mapping-guided atrial lead placement determines optimal conduction across Bachmann’s bundle: a rationale for patient-tailored pacing therapy},
journal = {EP Europace},
year = {2023},
volume = {25},
number = {4},
pages = {1432--1440},
doi = {10.1093/europace/euad039}
}
EUVIMED